The Environmental Genome Project is an effort by the NIEHS to characterize the variations in a number of important human genes and to relate these differences to susceptibility of humans to chemical and physical agents in the environment. The long-term goal of this work is to improve human health, primarily through improved prevention, but also through treatment when appropriate.
Why is there strong interest in this project? At least four major reasons can be identified. 1) The Human Genome Project is not finished, but there is broad support in the biomedical science community for the program and a general consensus that the work will be completed on schedule, even in the absence of major new developments in technology. Also, related government efforts are under way, such as the Centers for Disease Control National Health and Nutrition Examination Survey (NHANES) program and a National Cancer Institute effort to identify genes that show altered expression levels in tumors. All of this information will provide a knowledge base to use in disease prevention and treatment. 2) There is a long history of interest in inherited diseases, which resulted in the establishment of medical genetics and genetic epideminology as disciplines (1) . Many of these debilitating diseases were found to be disorders of primary metabolism. The reasoning is that if genetics contributes to rare diseases, then it should also contribute to more common ones. 3) Many studies with experimental animals show genetic influences on susceptibility to chemical and physical agents. For instance, mice deficient in the Ah locus show differences in cancer incidence and acute toxicity from a variety of chemicals (2) . Another relevant example in humans is the differential susceptibility to ultraviolet (UV) light due to functional differences in DNA repair genes (3,4). 4) Studies on human drug metabolism over the past 20 years have provided convincing evidence of the wide variability in function of the enzymes ofxenobiotic metabolism [e.g., cytochromes P450, N-acetyltransferases, and glutathione (GSH) transferases] and the in vivo significance of these variations in the disposition of these drugs in humans (5-7). In some cases, fatalities can be attributed to these differences (8) . Further, many of these same enzymes are known to be involved in the bioactivation and detoxication of potentially healthdamaging chemicals found in the environment (i.e., other than drugs).
Background
The goal of the Environmental Genome Project is to characterize allelic variants qualitatively and quantitatively. Variations from a predominant allele are often referred to as genetic polymorphisms, a term used to describe variants occurring at an incidence of >1%. Polymorphisms are common among humans. Some (19, 20) . A reported association of an epoxide hydrolase polymorphism with aflatoxin-related hepatocellular carcinoma (21) has also been questioned on a mechanistic basis (22) .
Although these are serious concerns about the discipline of dassical epidemiology, ultimately mechanism-based molecular epidemiology will be needed to establish the importance of paradigms developed in the laboratory. Returning to the analogy of drug development, many candidate compounds appear promising, but do not deliver efficacy in clinical trials. 
Problems in Functional Analysis

Strategies for Functional Analysis
In some cases assays can be done directly with humans. For instance, drugs are oxidized by some of the P450 enzymes under consideration here (5 
Multiple Approaches to Functional Analysis: Examples
An approach that will probably be more realistic is one that involves multiple strategies depending upon the gene under consideration. A few examples are considered.
In many respects, the enzymes involved in the metabolism of xenobiotic chemicals are easiest to deal with. After establishing the polymorphisms and frequency distribution, it may be expedient to first look for a correlation of the polymorphism and in vitro catalytic activity in human tissue samples. Various gene products can also be expressed readily in simple heterologous vector systems, and assays of catalytic activity can be done. These enzyme systems have the advantage that, in many cases, probe drug substrates are known that can be used in humans (5) , and studies on in vivo phenotyping/genotyping may be possible, as already have been done for enzymes such as P450s 2D6 and 2C19 (32) . If differences can be identified, work can be extended to epidemiological settings. A caveat in all of this is that the test (and probe) substrates may not be relevant to human health issues, so aspects such as the chemical etiology of disease must also be considered.
Another case involves enzymes related to oxidative stress. As with the case above, it is possible to look for correlation of the polymorphism and in vitro catalytic activity in human tissue samples, if relevant samples and an appropriate assay are available. The gene products can be expressed in simple systems, perhaps even microbial ones, and the abilities of the expressed gene products can be compared with regard to their abilities to protect from an induced oxidative stress. If microorganisms are used, some of the experiments might be repeated in mammalian cells. In the extension of the work to molecular epidemiology, one approach might be to look for biomarkers of oxidative stress [e.g., F2 isoprostanes (33) 
Conclusions
A few more points should be made. In the above considerations of the possible expression systems to use, one might ask why not use the most complex and relevant. However, if we work with 200 genes and each has 5-10 polymorphisms (a rough but not unreasonable estimate), we face the prospect of 1,000-2,000 expressions and doing the necessary assays. Therefore, some thought must be given to simplicity of systems and rapid assays.
Another problem already mentioned is that many of the effects may be small in themselves, and synergism of multiple phenotypes may be needed for a particular disease. For instance, one can consider the epidemiology work on colon cancer, where a mixture of a high level of P450 1A2 and the rapid phenotype for N-acetyltransferase 2 showed a synergism (along with consumption of well-done cooked beef) (35) . Further, we do not really know all of the functions of the genes we are exploring, due to various aspects of coupling. For instance, some proteins appear to be involved in both DNA repair and transcription (36) (37) (38) 
